Dr Anita Chandra - Publications

An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome

24 Feb 2023

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation

01 Dec 2020

Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma Model

01 Jul 2020

Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate

01 Jul 2020

Topoisomerase 2β mutation impairs early B-cell development

01 Apr 2020

Whole-genome sequencing of a sporadic primary immunodeficiency cohort

01 Jul 2020

Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ

09 May 2019

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

02 Mar 2018

PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner

01 Aug 2018

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

01 Mar 2018

Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome

01 Mar 2018